International Artal, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 26.51M shares in CAVA Group, Inc. (Ticker: CAVA), holds 1.15M shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 2.40M shares in Scholar Rock Holding (Ticker: SRRK). Most recently, International Artal Sold ― shares of CAVA Group, Inc. on Mar 25, 2024 for an estimated value of 132.50M.